AUDREY DRAKE: Open Payments
NPI 1093547291 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 61 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $136 · 2025 $1,943
Food & beverage: $1,943
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $208 |
| E.R. Squibb & Sons, L.L.C. | 15 | $188 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| Stemline Therapeutics Inc. | 2 | $151 |
| Tempus AI, Inc | 2 | $131 |
| ABBVIE INC. | 2 | $129 |
| Amgen Inc. | 1 | $125 |
| Incyte Corporation | 2 | $110 |
| TerSera Therapeutics LLC | 3 | $73 |
Products named: DARZALEX, OPDIVO, Orserdu, DATROWAY, XT CDX, IMDELLTRA (AMG757), EPKINLY, Jakafi.
Industry payments across OR — which companies pay providers there.
